Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Clinical trial NCT00179478 · COMPLETED

Trial details

NCT number: NCT00179478
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Optic Neuritis Transverse Myelitis Acute Brainstem/Cerebellar Syndrome

Start date: 2001-02-01
Primary completion: 2009-03-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.